Oventus Medical Limited chart

Last update: 2021-02-19
Key statistics and financials
Revenue per share 0.00
Dividend & YieldN/A$ (N/A)
Beta 0.89
Market capitalization 4.83M
Operating cash flow -8.69M
ESG Scores unknown

Company description

Oventus Medical Limited, a medical device company, develops and commercializes oral appliances for the treatment of obstructive sleep apnoea (OSA) and snoring in Australia, Canada, and the United States. The company offers O2Vent Optima, a 3D-printed nylon oral appliance for OSA patients; and ExVent, a valve accessory that fits into the open airway of the O2Vent Optima device. The company was incorporated in 2015 and is headquartered in Indooroopilly, Australia.

Sector: Healthcare - Industry: Medical Devices

Financial data

Financial Statements

Cashflow Statement 2018-06-30 2019-06-30 2020-06-30 2021-06-30
Change To Liabilities -527.57k 830.44k 307.83k 42.37k
Total Cashflows From Investing Activities -2M -1.88M -1.51M -1.53M
Net Borrowings -244.15k -244.15k -244.15k -244.15k
Total Cash From Financing Activities 7.91M 14.76M 14.76M 9.18M
Change To Operating Activities -167.82k 98.79k 136.13k -158.39k
Issuance Of Stock 8.36M 14.76M 14.76M 9.43M
Net Income -5.87M -7.85M -10.13M -9.83M
Change In Cash 1.25M -6.9M 5.46M 701.15k
Effect Of Exchange Rate -29.54k -106.45k -117.6k -28.16k
Total Cash From Operating Activities -4.64M -4.91M -7.67M -6.92M
Depreciation 293.25k 202.49k 377.98k 522.43k
Change To Account Receivables 257.88k 483.14k -100.05k -41.07k
Other Cashflows From Financing Activities -449.44k
Change To Netincome 915.37k 755.29k 586.79k 1.74M
Capital Expenditures -66.84k -66.84k -652.34k -154.83k

Income Statement 2018-06-30 2019-06-30 2020-06-30 2021-06-30
Research Development 269.06k 389.2k 571.83k 186.1k
Income Before Tax -5.87M -7.85M -10.13M -9.83M
Net Income -5.87M -7.85M -10.13M -9.83M
Selling General Administrative 5.22M 6.98M 8.62M 8.2M
Gross Profit 93.62k 173.6k 187.56k 401.62k
Ebit -6.15M -8.15M -10.84M -10.22M
Operating Income -6.15M -8.15M -10.84M -10.22M
Interest Expense -5.37k -5.37k -5.37k -30.69k
Income Tax Expense
Total Revenue 271.32k 331.84k 419.3k 1.09M
Cost Of Revenue 177.7k 158.24k 231.74k 687.91k
Total Other Income ExpenseNet 282.17k 306.71k 710.69k 391.84k
Net Income From Continuing Ops -5.87M -7.85M -10.13M -9.83M
Net Income Applicable To Common Shares -5.87M -7.85M -10.13M -9.83M

Balance Sheet Statement 2018-06-30 2019-06-30 2020-06-30 2021-06-30
Total Liabilities 682.24k 1.6M 2.11M 2.46M
Total Stockholder Equity 15.13M 7.36M 12.22M 12.62M
Other Current Liabilities 325.04k 642.38k 962.83k 966.57k
Total Assets 15.81M 8.96M 14.33M 15.08M
Common Stock 29.64M 29.64M 44.33M 53.64M
Other Current Assets 55.89k 141.43k 184.4k 191.8k
Retained Earnings -14.82M -22.67M -32.7M -42.11M
Treasury Stock 313.37k 387.96k 585.99k 1.08M
Cash 9.89M 3M 8.46M 9.16M
Total Current Liabilities 682.24k 1.53M 2.02M 2.1M
Other Stockholder Equity 313.37k 387.96k 585.99k 1.08M
Property, Plant, and Equipment 702.09k 699.4k 1.01M 1.4M
Total Current Assets 11.83M 4.44M 9.91M 10.49M
Net Tangible Assets 14.38M 6.3M 10.93M 11.37M
Net Receivables 1.66M 1.11M 768k 624.78k
Accounts Payable 232.63k 730.79k 512.63k 684.08k


Insider Transactions

Here are the insider transactions of stock shares related to Oventus Medical Limited:

Filer Name Transaction Text Ownership Date Filer Relation Shares
Hart (Christopher Patrick)D2022-06-07Former416k
Bridges (Melvyn John)D2021-11-18Former4.59M
Bridges (Melvyn John)Purchase at price 0.09 per share.D2021-10-13Director (Non-Executive)82.88k
Bridges (Melvyn John)Purchase at price 0.04 per share.D2021-09-22Director (Non-Executive)1.3M
MacLeman (Sue)Purchase at price 0.09 per share.D2021-09-10Non Executive Chairman86.96k
Denaro (Stephen)D2021-06-30Company Secretary166.67k
MacLeman (Sue)Other at price 0.09 per share.D2021-06-30Non Executive Chairman83.33k
Molloy (Paul)Other at price 0.09 per share.D2021-06-30Director (Non-Executive)416.67k
Bridges (Melvyn John)Other at price 0.09 per share.D2021-06-30Director (Non-Executive)166.67k
Nunn (Jason R. CFA)D2021-06-30Director (Non-Executive)208.33k
Hart (Christopher Patrick)Other at price 0.09 per share.D2021-06-29Director (Executive)791.67k
Hart (Christopher Patrick)Other at price 0.09 per share.D2021-06-21Director (Executive)208.33k
MacLeman (Sue)Other at price 0.16 per share.D2020-06-18Director (Non-Executive)1.98k
Bridges (Melvyn John)D2020-06-18Chairman of the Board156.9k
Nunn (Jason R. CFA)Other at price 0.16 per share.D2020-06-18Director (Non-Executive)156.25k
Bridges (Melvyn John)Purchase at price 0.11 per share.D2020-03-25Chairman of the Board104.69k
MacLeman (Sue)Purchase at price 0.12 per share.D2020-03-25Director (Non-Executive)10.69k
Bridges (Melvyn John)D2019-08-28Chairman of the Board135.94k
MacLeman (Sue)Other at price 0.26 per share.D2019-08-28Director (Non-Executive)1.98k
Bridges (Melvyn John)D2019-05-21Chairman of the Board120k
MacLeman (Sue)Purchase at price 0.21 per share.D2019-03-05Director16.5k
Bridges (Melvyn John)Purchase at price 0.22 per share.D2019-02-26Chairman of the Board116.28k
Bridges (Melvyn John)D2019-02-22Chairman of the Board120.22k
Bridges (Melvyn John)D2018-07-20Chairman of the Board91.8k
Bridges (Melvyn John)D2018-06-18Chairman of the Board127.75k
Bridges (Melvyn John)Purchase at price 0.29 per share.D2018-04-10Chairman of the Board21k
Bridges (Melvyn John)D2018-03-29Chairman of the Board106.8k
Bridges (Melvyn John)D2017-12-21Chairman of the Board108k
Bridges (Melvyn John)D2017-11-20Chairman of the Board191.3k
MacLeman (Sue)Purchase at price 0.29 per share.D2017-09-14Director3k
Anderson (Neil Lawrence)Other at price 0.28 per share.D2017-08-09Chief Executive Officer138.89k
Hart (Christopher Patrick)Other at price 0.28 per share.D2017-08-09Director375k
Bridges (Melvyn John)Acquisition at price 0.28 per share.D2017-08-09Chairman of the Board652.78k
Hart (Christopher Patrick)Purchase at price 0.51 per share.D2017-03-17Director21k
Bridges (Melvyn John)Purchase at price 0.52 per share.D2017-03-06Chairman of the Board29.25k
Hart (Christopher Patrick)Purchase at price 0.53 per share.D2017-03-02Director19k
Hart (Christopher Patrick)Purchase at price 0.51 per share.D2017-03-02Director1k
Bridges (Melvyn John)Purchase at price 0.54 per share.D2016-11-28Chairman of the Board38.45k
Bridges (Melvyn John)Purchase at price 0.52 per share.D2016-11-25Chairman of the Board1.75k
Bridges (Melvyn John)Purchase at price 0.65 per share.D2016-07-25Chairman of the Board80k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Oventus Medical Limited. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Oventus Medical Limited

Here is the result of two systematic investment strategies applied to Oventus Medical Limited. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Oventus Medical Limited

The following chart shows the equity curve of the two systematic investment strategies applied to Oventus Medical Limited:

Oventus Medical Limited automated entries

The systematic investment strategy that buys the first day of the month would give a performance of -35.14% on the backtest period.

Performance at glance

Performance

-35.14 %

Latent gain

-878.2 $

Invested capital

2499.3 $

Annualized return

-7.71 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Oventus Medical Limited

This is the result of two momentum investment strategies applied to Oventus Medical Limited. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Oventus Medical Limited

The following chart shows all the entries opened by the momentum investment system on Oventus Medical Limited:

Oventus Medical Limited momentum entries
  • The first momentum investment strategy would give -31.7% of return on Oventus Medical Limited. That represents -2060.56$ of latent gain with 6499.88$ of employed capital.
  • The second momentum investment strategy would give -25.61% of return on Oventus Medical Limited. That represents -1024.18$ of latent gain with 3999.56$ of employed capital.
Performance at glance (1Q Momentum)

Performance

-31.7 %

Latent gain

-2060.56 $

Invested capital

6499.88 $

Annualized return

-20.46 %
Performance at glance (2Q Momentum)

Performance

-25.61 %

Latent gain

-1024.18 $

Invested capital

3999.56 $

Annualized return

-6.28 %

Momentum equity curve on Oventus Medical Limited

The following chart shows the equity curve of the two momentum strategies applied to Oventus Medical Limited:

Oventus Medical Limited momentum equity

Note: the dividends potentially given by Oventus Medical Limited are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Oventus Medical Limited

The following chart shows the employed capital evolution of the two momentum strategies on Oventus Medical Limited since the beginning:

Oventus Medical Limited

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Oventus Medical Limited

Buy the dip entry openings on Oventus Medical Limited

Oventus Medical Limited

The performance achieved by the robo-advisor on Oventus Medical Limited is -52.37%. That represents -523.78$ of latent gain with 1000.22$ of employed capital. The following chart shows Oventus Medical Limited stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Oventus Medical Limited, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

-52.37 %

Latent gain

-523.78 $

Invested capital

1000.22 $

Annualized return

-20.46 %

Equity curve of the strategy applied to Oventus Medical Limited

The following chart shows the result of the investment strategy applied to Oventus Medical Limited:

Oventus Medical Limited

Note: the dividends potentially given by Oventus Medical Limited are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Oventus Medical Limited

The following chart shows the employed capital evolution since the beginning of the investment strategy on Oventus Medical Limited:

Oventus Medical Limited

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Oventus Medical Limited

In this section, I will compare the three previous investment strategies applied to Oventus Medical Limited.

Equity curve comparison on Oventus Medical Limited

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Oventus Medical Limited investment strategy comparison

Employed capital comparison on Oventus Medical Limited

Oventus Medical Limited investment comparison

Performance comparison on Oventus Medical Limited

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment -35.14% -878.2$ 2499.3$ -7.71%
Momentum 1 quarter -31.7% -2060.56$ 6499.88$ -7.34%
Momentum 2 quarters -25.61% -1024.18$ 3999.56$ -6.28%
Non-directional -52.37% -523.78$ 1000.22$ -20.46%
Annualized return comparison

Automatic investment

-7.71 %

Momentum 1Q

-6.28 %

Momentum 2Q

-6.28 %

Non-directional

-20.46 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Oventus Medical Limited:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between Oventus Medical Limited and the other stocks. There may be false positives or some missing correlated stocks. If the price of Oventus Medical Limited does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name Oventus Medical Limited
Country Australia
City Indooroopilly
Address 1 Swann Road
Phone 61 3 0053 3159
Website o2vent.com
FullTime employees
Industry Medical Devices
Sector Healthcare
Exchange XASX
Ticker OVN.XASX
Market www2.asx.com.au

Oventus Medical Limited ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown